Trifluridine
(trye flur' i deen).
Click to View Image
C10H11F3N2O5 296.20

Thymidine, ,,-trifluoro-.
2¢-Deoxy-5-(trifluoromethyl)uridine [70-00-8].
» Trifluridine contains not less than 98.0 percent and not more than 102.0 percent of C10H11F3N2O5, calculated on the dried basis.
Packaging and storage— Preserve in tight, light-resistant containers.
USP Reference standards 11
USP Trifluridine RS Click to View Structure
USP Trifluridine Related Compound A RS Click to View Structure
5-Carboxy-2¢-deoxyuridine.
    C10H12N2O7    272.22
Identification—
B: Ultraviolet Absorption 197U
Solution: 25 µg per mL.
Medium: 0.1 N hydrochloric acid.
C: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Loss on drying 731 Dry it in vacuum at 105 for 4 hours: it loses not more than 1.0% of its weight.
Specific rotation 781S: between +47 and +51.
Test solution: 30 mg per mL, in water.
Related compounds—
Mobile phase and Chromatographic system— Proceed as directed in the Assay.
Standard solution— Use the Standard preparation prepared as directed in the Assay.
Test solution— Use the Assay preparation.
Procedure— Proceed as directed in the Assay. Calculate the percentages of trifluridine related compound A and 5-(trifluoromethyl)uracil in the portion of Trifluridine taken by the formula:
25,000(C / W)(rU / rS)
in which C is the concentration, in mg per mL, of USP Trifluridine Related Compound A RS and 5-(trifluoromethyl)uracil in the Standard solution; W is the weight, in mg, of Trifluridine taken; and rU and rS are the peak responses for the related compounds obtained from the Test solution and the Standard solution, respectively: not more than 1.0% of each related compound is found.
Assay—
Mobile phase— Prepare a filtered and degassed 0.15% sodium citrate solution and adjust with 1 N hydrochloric acid to a pH of 6.8. Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard stock preparation— Dissolve accurately weighed quantities of USP Trifluridine RS, USP Trifluridine Related Compound A RS, and 5-(trifluoromethyl)uracil in water to obtain a solution having known concentrations of about 1 mg per mL, 0.01 mg per mL, and 0.01 mg per mL, respectively. [note—This stock preparation may be stored at 0 to 5 for 3 months. ]
Standard preparation— Transfer 10.0 mL of the Standard stock preparation to a 50-mL volumetric flask, dilute with water to volume, and mix.
Assay preparation— Transfer about 50 mg of Trifluridine, accurately weighed, to a 250-mL volumetric flask, dissolve in and dilute with water to volume, and mix.
Chromatographic system (see Chromatography 621) The liquid chromatograph is equipped with a 254-nm detector and a 4.2-mm × 25-cm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the resolution, R, between 5-(trifluoromethyl)uracil and trifluridine related compound A is not less than 3.0 and between trifluridine related compound A and trifluridine is not less than 4.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity, in mg, of C10H11F3N2O5 in the portion of Trifluridine taken by the formula:
250C(rU / rS)
in which C is the concentration, in mg per mL, of USP Trifluridine RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Leonel M. Santos, Ph.D.
Senior Scientific Liaison
1-301-816-8168
(SM12010) Monographs - Small Molecules 1
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP35–NF30 Page 4947
Pharmacopeial Forum: Volume No. 27(1) Page 1823